Table 2.
Jansens[33](Netherlands) | Jansens[33](USA) | Wedderkopp[35] | LeResche[34] | Hulsegge[32] | ||
---|---|---|---|---|---|---|
1. Study sample | - Was the sampling likely to be suitable to obtain a group representative of the corresponding general population? | Yes (Probably) | Yes (Probably) | Yes (Probably) | Yes (Probably) | Yes (Probably) |
- If participation at BL or at FU < 80%, was response bias investigated? | Yes | Yes | Yes | Yes | No | |
- Inclusion criteria, were age groups appropriate to study the whole period of puberty? | Yes | Yes | Yes | Yes | Not really | |
2. Data collec-tion | - Data for BP and puberty were collected independently by 2 different persons or by at least 1 questionnaire? | Yes | No | Yes | No | Yes |
3. Puberty | - Clearly defined? | Yes | Yes | Yes | Yes | Yes |
- Description of how puberty stage was determined? | Yes | Yes | Yes | Yes | Yes | |
-Reference provided for validity of test? | No | No | No | Yes | Yes | |
-Reference provided for reliability of test? | Yes | Yes | No | No | No | |
4. Back pain | - Clearly defined? | Yes | Yes | Yes | Yes | Yes |
- Description of how BP was assessed? | Yes | Yes | Yes | Yes | Yes | |
- Recall period (<= 1-month)? | No | No | Yes | No | No | |
- Was BP at BL taken into account? | Yes | Yes | NA | NA | NA | |
5. Control for age and sex | - Was the association puberty- BP controlled for age? | Yes | Yes | Stratified analysis | Yes | Yes |
- for sex? | Yes | Yes | NA | Stratified analysis | Yes | |
6. Stat. analysis | - Was dose-response prevalence estimated in relation to puberty stages investigated? | Yes | Yes | Yes | Yes | No |
- Was dose-response of frequency or severity in relation to puberty stages investigated? | No | No | NA | NA | NA | |
- Was dose-response tested for trend? | Yes | Yes | Yes | Yes | Yes | |
Score (0-17)% | 14/17 | 13/17 | 12/14 | 12/15 | 10/15 | |
82% | 76% | 86% | 80% | 67% |
(listed by the quality score).
BL = baseline, FU = follow up, BP = back pain, NA = not applicable.